Class 3 FMD Medicines Recall: Beconase Aqueous Nasal Spray (Glaxo Wellcome UK Ltd T/A GSK)

Class 3 FMD Medicines Recall: Beconase Aqueous Nasal Spray (Glaxo Wellcome UK Ltd T/A GSK)

February 12, 2020

MDR number: 011-02/20

Drug alert number: EL (20)A/07 

Date issued: 12 February 2020

The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 FMD medicines recall for:

Beconase Aqueous Nasal Spray (Beclometasone Dipropionate 50μg) – Glaxo Wellcome UK Ltd T/A GSK

Glaxo Wellcome UK Ltd T/A GSK has informed the MHRA of an issue related to error in the decommissioning of the batches listed below. Upon decommissioning at the pharmacy and when scanning the serialised 2D code, the status of packs may report as ‘DESTROYED.’ Although there is no risk to product quality, any remaining stock should be quarantined and returned.

Batch Number Expiry Date Pack Size First Distributed
K84X 09-2021 1 06-Jan-2020

Advice for healthcare professionals

Stop supplying the batch listed above immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Full drug alert can be viewed here.

Company contacts for further information
For stock control enquiries please contact 0800 221441

For medical information enquiries please contact ukmedinfo@gsk.com, via the Live Chat facility or on 0800 221 441 (option 2).



Posted in: ,


More Latest News >